Three years ago I wrote approximately an experimental treatment for chronic fatigue syndrome (CFS): rituximab (brand name Rituxan). I was concerned that doctors who offered it,like Andreas Kogelnik, were jumping the gun by offering it before the evidence was in, or that they might be putting patients at risk. A correspondent who has been […]
Source: sciencebasedmedicine.org